Biomednewsbreaks - Clene Inc. (NASDAQ: CLNN) Looking To Transform Healthcare For Individuals With Neurodegenerative ...
(MENAFN- Investor Brand Network) Clene (NASDAQ: CLNN) has innovated CNM-Au8(R), an oral nanotherapeutic designed to revitalize the brain's mitochondrial function, which is a significant advancement for the treatment of neurodegenerative disease.“The …